tiprankstipranks
Trending News
More News >
Vaxcyte, Inc. (PCVX)
NASDAQ:PCVX
US Market

Vaxcyte (PCVX) Income Statement

Compare
435 Followers

Vaxcyte Income Statement

Last quarter (Q3 2025), Vaxcyte's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Vaxcyte's net income was $-212.83M. See Vaxcyte’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -1.41M
Operating Expenses
$ 569.55M$ 468.04M$ 232.26M$ 103.67M$ 88.18M
Depreciation and Amortization
$ 15.85M$ 10.17M$ 9.45M$ 3.46M$ 1.41M
EBITDA
$ -448.08M$ -392.10M$ -214.03M$ -96.61M$ -87.81M
Operating Income
$ -569.55M$ -468.04M$ -232.26M$ -103.67M$ -89.58M
Other Income/Expenses
$ 105.62M$ 65.78M$ 8.77M$ 3.59M$ 364.00K
Pretax Income
$ -463.93M$ -402.27M$ -223.49M$ -100.08M$ -89.22M
Net Income
$ -463.93M$ -402.27M$ -223.49M$ -100.08M$ -89.22M
Per Share Metrics
Basic EPS
$ -3.80$ -4.14$ -3.44$ -1.93$ -2.97
Diluted EPS
$ -3.80$ -4.14$ -3.44$ -1.93$ -2.97
Weighted Average Shares Outstanding
122.00M 97.16M 64.88M 51.92M 29.55M
Weighted Average Shares Outstanding (Diluted)
122.00M 97.16M 64.88M 51.92M 29.55M
Currency in USD

Vaxcyte Earnings and Revenue History